Genotype-phenotype correlations and novel molecular insights into the DHX30-associated neurodevelopmental disorders.


Journal

Genome medicine
ISSN: 1756-994X
Titre abrégé: Genome Med
Pays: England
ID NLM: 101475844

Informations de publication

Date de publication:
21 05 2021
Historique:
received: 02 09 2020
accepted: 28 04 2021
entrez: 22 5 2021
pubmed: 23 5 2021
medline: 19 2 2022
Statut: epublish

Résumé

We aimed to define the clinical and variant spectrum and to provide novel molecular insights into the DHX30-associated neurodevelopmental disorder. Clinical and genetic data from affected individuals were collected through Facebook-based family support group, GeneMatcher, and our network of collaborators. We investigated the impact of novel missense variants with respect to ATPase and helicase activity, stress granule (SG) formation, global translation, and their effect on embryonic development in zebrafish. SG formation was additionally analyzed in CRISPR/Cas9-mediated DHX30-deficient HEK293T and zebrafish models, along with in vivo behavioral assays. We identified 25 previously unreported individuals, ten of whom carry novel variants, two of which are recurrent, and provide evidence of gonadal mosaicism in one family. All 19 individuals harboring heterozygous missense variants within helicase core motifs (HCMs) have global developmental delay, intellectual disability, severe speech impairment, and gait abnormalities. These variants impair the ATPase and helicase activity of DHX30, trigger SG formation, interfere with global translation, and cause developmental defects in a zebrafish model. Notably, 4 individuals harboring heterozygous variants resulting either in haploinsufficiency or truncated proteins presented with a milder clinical course, similar to an individual harboring a de novo mosaic HCM missense variant. Functionally, we established DHX30 as an ATP-dependent RNA helicase and as an evolutionary conserved factor in SG assembly. Based on the clinical course, the variant location, and type we establish two distinct clinical subtypes. DHX30 loss-of-function variants cause a milder phenotype whereas a severe phenotype is caused by HCM missense variants that, in addition to the loss of ATPase and helicase activity, lead to a detrimental gain-of-function with respect to SG formation. Behavioral characterization of dhx30-deficient zebrafish revealed altered sleep-wake activity and social interaction, partially resembling the human phenotype. Our study highlights the usefulness of social media to define novel Mendelian disorders and exemplifies how functional analyses accompanied by clinical and genetic findings can define clinically distinct subtypes for ultra-rare disorders. Such approaches require close interdisciplinary collaboration between families/legal representatives of the affected individuals, clinicians, molecular genetics diagnostic laboratories, and research laboratories.

Sections du résumé

BACKGROUND
We aimed to define the clinical and variant spectrum and to provide novel molecular insights into the DHX30-associated neurodevelopmental disorder.
METHODS
Clinical and genetic data from affected individuals were collected through Facebook-based family support group, GeneMatcher, and our network of collaborators. We investigated the impact of novel missense variants with respect to ATPase and helicase activity, stress granule (SG) formation, global translation, and their effect on embryonic development in zebrafish. SG formation was additionally analyzed in CRISPR/Cas9-mediated DHX30-deficient HEK293T and zebrafish models, along with in vivo behavioral assays.
RESULTS
We identified 25 previously unreported individuals, ten of whom carry novel variants, two of which are recurrent, and provide evidence of gonadal mosaicism in one family. All 19 individuals harboring heterozygous missense variants within helicase core motifs (HCMs) have global developmental delay, intellectual disability, severe speech impairment, and gait abnormalities. These variants impair the ATPase and helicase activity of DHX30, trigger SG formation, interfere with global translation, and cause developmental defects in a zebrafish model. Notably, 4 individuals harboring heterozygous variants resulting either in haploinsufficiency or truncated proteins presented with a milder clinical course, similar to an individual harboring a de novo mosaic HCM missense variant. Functionally, we established DHX30 as an ATP-dependent RNA helicase and as an evolutionary conserved factor in SG assembly. Based on the clinical course, the variant location, and type we establish two distinct clinical subtypes. DHX30 loss-of-function variants cause a milder phenotype whereas a severe phenotype is caused by HCM missense variants that, in addition to the loss of ATPase and helicase activity, lead to a detrimental gain-of-function with respect to SG formation. Behavioral characterization of dhx30-deficient zebrafish revealed altered sleep-wake activity and social interaction, partially resembling the human phenotype.
CONCLUSIONS
Our study highlights the usefulness of social media to define novel Mendelian disorders and exemplifies how functional analyses accompanied by clinical and genetic findings can define clinically distinct subtypes for ultra-rare disorders. Such approaches require close interdisciplinary collaboration between families/legal representatives of the affected individuals, clinicians, molecular genetics diagnostic laboratories, and research laboratories.

Identifiants

pubmed: 34020708
doi: 10.1186/s13073-021-00900-3
pii: 10.1186/s13073-021-00900-3
pmc: PMC8140440
doi:

Substances chimiques

Biomarkers 0
DHX30 protein, human EC 2.7.7.-
RNA Helicases EC 3.6.4.13

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

90

Subventions

Organisme : NINDS NIH HHS
ID : K23 NS117310
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM135175
Pays : United States
Organisme : NIH HHS
ID : U54 OD030167
Pays : United States

Références

Jankowsky E. RNA helicases at work: binding and rearranging. Trends Biochem Sci. 2011;36(1):19–29. https://doi.org/10.1016/j.tibs.2010.07.008 .
doi: 10.1016/j.tibs.2010.07.008 pubmed: 20813532 pmcid: 3017212
Linder P, Jankowsky E. From unwinding to clamping - the DEAD box RNA helicase family. Nat Rev Mol Cell Biol. 2011;12(8):505–16. https://doi.org/10.1038/nrm3154 .
doi: 10.1038/nrm3154 pubmed: 21779027
Umate P, Tuteja N, Tuteja R. Genome-wide comprehensive analysis of human helicases. Commun Integr Biol. 2011;4(1):118–37. https://doi.org/10.4161/cib.13844 .
doi: 10.4161/cib.13844 pubmed: 21509200 pmcid: 3073292
Heerma van Voss MR, van Diest PJ, Raman V. Targeting RNA helicases in cancer: The translation trap. Biochim Biophys Acta Rev Cancer. 2017;1868(2):510–20. https://doi.org/10.1016/j.bbcan.2017.09.006 .
doi: 10.1016/j.bbcan.2017.09.006 pubmed: 28965870
Cai W, Xiong Chen Z, Rane G, Satendra Singh S, Choo Z, Wang C, et al. Wanted DEAD/H or Alive: Helicases Winding Up in Cancers. J Natl Cancer Inst. 2017;109(6):djw278. https://doi.org/10.1093/jnci/djw278 .
doi: 10.1093/jnci/djw278
Snijders Blok L, Madsen E, Juusola J, Gilissen C, Baralle D, Reijnders MR, et al. Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling. Am J Hum Genet. 2015;97(2):343–52. https://doi.org/10.1016/j.ajhg.2015.07.004 .
doi: 10.1016/j.ajhg.2015.07.004 pubmed: 26235985 pmcid: 4573244
Balak C, Benard M, Schaefer E, Iqbal S, Ramsey K, Ernoult-Lange M, et al. Rare De Novo Missense Variants in RNA Helicase DDX6 Cause Intellectual Disability and Dysmorphic Features and Lead to P-Body Defects and RNA Dysregulation. Am J Hum Genet. 2019;105(3):509–25. https://doi.org/10.1016/j.ajhg.2019.07.010 .
doi: 10.1016/j.ajhg.2019.07.010 pubmed: 31422817 pmcid: 6731366
Lessel D, Schob C, Kury S, Reijnders MRF, Harel T, Eldomery MK, et al. De Novo Missense Mutations in DHX30 Impair Global Translation and Cause a Neurodevelopmental Disorder. Am J Hum Genet. 2017;101(5):716–24. https://doi.org/10.1016/j.ajhg.2017.09.014 .
doi: 10.1016/j.ajhg.2017.09.014 pubmed: 29100085 pmcid: 5673606
Shamseldin HE, Rajab A, Alhashem A, Shaheen R, Al-Shidi T, Alamro R, et al. Mutations in DDX59 implicate RNA helicase in the pathogenesis of orofaciodigital syndrome. Am J Hum Genet. 2013;93(3):555–60. https://doi.org/10.1016/j.ajhg.2013.07.012 .
doi: 10.1016/j.ajhg.2013.07.012 pubmed: 23972372 pmcid: 3769930
Paine I, Posey JE, Grochowski CM, Jhangiani SN, Rosenheck S, Kleyner R, et al. Paralog Studies Augment Gene Discovery: DDX and DHX Genes. Am J Hum Genet. 2019;105(2):302–16. https://doi.org/10.1016/j.ajhg.2019.06.001 .
doi: 10.1016/j.ajhg.2019.06.001 pubmed: 31256877 pmcid: 6698803
Cross LA, McWalter K, Keller-Ramey J, Henderson LB, Amudhavalli SM. A report of gonadal mosaicism in DHX30-related neurodevelopmental disorder. Clin Dysmorphol. 2020;29(3):161–4. https://doi.org/10.1097/MCD.0000000000000316 .
doi: 10.1097/MCD.0000000000000316 pubmed: 31929335
Lessel D, Zeitler DM, Reijnders MRF, Kazantsev A, Hassani Nia F, Bartholomaus A, et al. Germline AGO2 mutations impair RNA interference and human neurological development. Nat Commun. 2020;11(1):5797. https://doi.org/10.1038/s41467-020-19572-5 .
doi: 10.1038/s41467-020-19572-5 pubmed: 33199684 pmcid: 7670403
Lee H, Deignan JL, Dorrani N, Strom SP, Kantarci S, Quintero-Rivera F, et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA. 2014;312(18):1880–7. https://doi.org/10.1001/jama.2014.14604 .
doi: 10.1001/jama.2014.14604 pubmed: 25326637 pmcid: 4278636
Lessel D, Gehbauer C, Bramswig NC, Schluth-Bolard C, Venkataramanappa S, van Gassen KLI, et al. BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells. Brain. 2018;141(8):2299–311. https://doi.org/10.1093/brain/awy173 .
doi: 10.1093/brain/awy173 pubmed: 29985992 pmcid: 6061686
Retterer K, Juusola J, Cho MT, Vitazka P, Millan F, Gibellini F, et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med. 2016;18(7):696–704. https://doi.org/10.1038/gim.2015.148 .
doi: 10.1038/gim.2015.148
Deciphering Developmental Disorders S. Prevalence and architecture of de novo mutations in developmental disorders. Nature. 2017;542(7642):433–8. https://doi.org/10.1038/nature21062 .
doi: 10.1038/nature21062
Sadedin SP, Dashnow H, James PA, Bahlo M, Bauer DC, Lonie A, et al. Cpipe: a shared variant detection pipeline designed for diagnostic settings. Genome Med. 2015;7(1):68. https://doi.org/10.1186/s13073-015-0191-x .
doi: 10.1186/s13073-015-0191-x pubmed: 26217397 pmcid: 4515933
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24. https://doi.org/10.1038/gim.2015.30 .
doi: 10.1038/gim.2015.30 pubmed: 25741868 pmcid: 4544753
Ji J, Lee H, Argiropoulos B, Dorrani N, Mann J, Martinez-Agosto JA, et al. DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies. Eur J Hum Genet. 2015;23(11):1473–81. https://doi.org/10.1038/ejhg.2015.71 .
doi: 10.1038/ejhg.2015.71 pubmed: 25944381 pmcid: 4613469
Kearney HM, Thorland EC, Brown KK, Quintero-Rivera F, South ST, Working Group of the American College of Medical Genetics Laboratory Quality Assurance C. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med. 2011;13(7):680–5. https://doi.org/10.1097/GIM.0b013e3182217a3a .
doi: 10.1097/GIM.0b013e3182217a3a pubmed: 21681106
Sobreira N, Schiettecatte F, Boehm C, Valle D, Hamosh A. New tools for Mendelian disease gene identification: PhenoDB variant analysis module; and GeneMatcher, a web-based tool for linking investigators with an interest in the same gene. Hum Mutat. 2015;36(4):425–31. https://doi.org/10.1002/humu.22769 .
doi: 10.1002/humu.22769 pubmed: 25684268 pmcid: 4820250
Guenther UP, Handoko L, Laggerbauer B, Jablonka S, Chari A, Alzheimer M, et al. IGHMBP2 is a ribosome-associated helicase inactive in the neuromuscular disorder distal SMA type 1 (DSMA1). Hum Mol Genet. 2009;18(7):1288–300. https://doi.org/10.1093/hmg/ddp028 .
doi: 10.1093/hmg/ddp028 pubmed: 19158098
Tseng-Rogenski SS, Chang TH. RNA unwinding assay for DExD/H-box RNA helicases. Methods Mol Biol. 2004;257:93–102. https://doi.org/10.1385/1-59259-750-5:093 .
doi: 10.1385/1-59259-750-5:093 pubmed: 14769999
Thomas HR, Percival SM, Yoder BK, Parant JM. High-throughput genome editing and phenotyping facilitated by high resolution melting curve analysis. PLoS One. 2014;9(12):e114632. https://doi.org/10.1371/journal.pone.0114632 .
doi: 10.1371/journal.pone.0114632 pubmed: 25503746 pmcid: 4263700
Ruzzo EK, Perez-Cano L, Jung JY, Wang LK, Kashef-Haghighi D, Hartl C, et al. Inherited and De Novo Genetic Risk for Autism Impacts Shared Networks. Cell. 2019;178(4):850–66 e826. https://doi.org/10.1016/j.cell.2019.07.015 .
doi: 10.1016/j.cell.2019.07.015 pubmed: 31398340 pmcid: 7102900
Tanner NK, Linder P. DExD/H box RNA helicases: from generic motors to specific dissociation functions. Mol Cell. 2001;8:251–62.
doi: 10.1016/S1097-2765(01)00329-X
Caruthers JM, McKay DB. Helicase structure and mechanism. Curr Opin Struct Biol. 2002;12(1):123–33. https://doi.org/10.1016/S0959-440X(02)00298-1 .
doi: 10.1016/S0959-440X(02)00298-1 pubmed: 11839499
Buttner K, Nehring S, Hopfner KP. Structural basis for DNA duplex separation by a superfamily-2 helicase. Nat Struct Mol Biol. 2007;14(7):647–52. https://doi.org/10.1038/nsmb1246 .
doi: 10.1038/nsmb1246 pubmed: 17558417
Tauchert MJ, Fourmann JB, Luhrmann R, Ficner R. Structural insights into the mechanism of the DEAH-box RNA helicase Prp43. Elife. 2017;6. https://doi.org/10.7554/eLife.21510 .
Prabu JR, Muller M, Thomae AW, Schussler S, Bonneau F, Becker PB, et al. Structure of the RNA Helicase MLE Reveals the Molecular Mechanisms for Uridine Specificity and RNA-ATP Coupling. Mol Cell. 2015;60(3):487–99. https://doi.org/10.1016/j.molcel.2015.10.011 .
doi: 10.1016/j.molcel.2015.10.011 pubmed: 26545078
Murakami K, Nakano K, Shimizu T, Ohto U. The crystal structure of human DEAH-box RNA helicase 15 reveals a domain organization of the mammalian DEAH/RHA family. Acta Crystallogr F Struct Biol Commun. 2017;73(6):347–55. https://doi.org/10.1107/S2053230X17007336 .
doi: 10.1107/S2053230X17007336 pubmed: 28580923 pmcid: 5458392
Luscan A, Laurendeau I, Malan V, Francannet C, Odent S, Giuliano F, et al. Mutations in SETD2 cause a novel overgrowth condition. J Med Genet. 2014;51(8):512–7. https://doi.org/10.1136/jmedgenet-2014-102402 .
doi: 10.1136/jmedgenet-2014-102402 pubmed: 24852293
Lumish HS, Wynn J, Devinsky O, Chung WK. Brief Report: SETD2 Mutation in a Child with Autism, Intellectual Disabilities and Epilepsy. J Autism Dev Disord. 2015;45(11):3764–70. https://doi.org/10.1007/s10803-015-2484-8 .
doi: 10.1007/s10803-015-2484-8
O'Roak BJ, Vives L, Fu W, Egertson JD, Stanaway IB, Phelps IG, et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science. 2012;338(6114):1619–22. https://doi.org/10.1126/science.1227764 .
doi: 10.1126/science.1227764 pubmed: 23160955 pmcid: 3528801
Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alfoldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434–43. https://doi.org/10.1038/s41586-020-2308-7 .
doi: 10.1038/s41586-020-2308-7 pubmed: 32461654 pmcid: 7334197
Petrovski S, Wang Q, Heinzen EL, Allen AS, Goldstein DB. Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet. 2013;9(8):e1003709. https://doi.org/10.1371/journal.pgen.1003709 .
doi: 10.1371/journal.pgen.1003709 pubmed: 23990802 pmcid: 3749936
Hempel M, Cremer K, Ockeloen CW, Lichtenbelt KD, Herkert JC, Denecke J, et al. De Novo Mutations in CHAMP1 Cause Intellectual Disability with Severe Speech Impairment. Am J Hum Genet. 2015;97(3):493–500. https://doi.org/10.1016/j.ajhg.2015.08.003 .
doi: 10.1016/j.ajhg.2015.08.003 pubmed: 26340335 pmcid: 4564986
Baneyx F, Mujacic M. Recombinant protein folding and misfolding in Escherichia coli. Nat Biotechnol. 2004;22(11):1399–408. https://doi.org/10.1038/nbt1029 .
doi: 10.1038/nbt1029 pubmed: 15529165
Davis EE, Frangakis S, Katsanis N. Interpreting human genetic variation with in vivo zebrafish assays. Biochim Biophys Acta. 1842;2014:1960–70.
Finckbeiner S, Ko PJ, Carrington B, Sood R, Gross K, Dolnick B, et al. Transient knockdown and overexpression reveal a developmental role for the zebrafish enosf1b gene. Cell Biosci. 2011;1:32.
doi: 10.1186/2045-3701-1-32
Zampedri C, Tinoco-Cuellar M, Carrillo-Rosas S, Diaz-Tellez A, Ramos-Balderas JL, Pelegri F, et al. Zebrafish P54 RNA helicases are cytoplasmic granule residents that are required for development and stress resilience. Biol Open. 2016;5(10):1473–84. https://doi.org/10.1242/bio.015826 .
doi: 10.1242/bio.015826 pubmed: 27489304 pmcid: 5087673
Wolozin B, Ivanov P. Stress granules and neurodegeneration. Nat Rev Neurosci. 2019;20(11):649–66. https://doi.org/10.1038/s41583-019-0222-5 .
doi: 10.1038/s41583-019-0222-5 pubmed: 31582840 pmcid: 6986315
Zhang YJ, Gendron TF, Ebbert MTW, O'Raw AD, Yue M, Jansen-West K, et al. Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis. Nat Med. 2018;24(8):1136–42. https://doi.org/10.1038/s41591-018-0071-1 .
doi: 10.1038/s41591-018-0071-1 pubmed: 29942091 pmcid: 6520050
Sorribes A, Thornorsteinsson H, Arnardottir H, Johannesdottir I, Sigurgeirsson B, de Polavieja GG, et al. The ontogeny of sleep-wake cycles in zebrafish: a comparison to humans. Front Neural Circuits. 2013;7:178.
doi: 10.3389/fncir.2013.00178
Patowary A, Won SY, Oh SJ, Nesbitt RR, Archer M, Nickerson D, et al. Family-based exome sequencing and case-control analysis implicate CEP41 as an ASD gene. Transl Psychiatry. 2019;9(1):4. https://doi.org/10.1038/s41398-018-0343-z .
doi: 10.1038/s41398-018-0343-z pubmed: 30664616 pmcid: 6341097
Fokkema IF, Taschner PE, Schaafsma GC, Celli J, Laros JF, den Dunnen JT. LOVD v.2.0: the next generation in gene variant databases. Hum Mutat. 2011;32(5):557–63. https://doi.org/10.1002/humu.21438 .
doi: 10.1002/humu.21438 pubmed: 21520333
Mannucci I, Dang NDP, Huber H, Murry JB, Abramson J, Althoff T, Banka S, Baynam G, Bearden D, Beleza A, Benke PJ, Berland S, Bierhals T, Bilan F, Bindoff LA, Braathen GJ, L. Busk Ø, Chenbhanich J, Denecke J, Escobar LF, Estes C, Fleischer J, Groepper D, Haaxma CA, Hempel M, Holler-Managan Y, Houge G, Jackson A, Kellogg L, Keren B, Kiraly-Borri C, Kraus C, Kubisch C, Le Guyader G, Ljungblad UW, Brenman LM, Martinez-Agosto JA, Might M, Miller DT, Minks KQ, Moghaddam B, Nava C, Nelson SF, Parant JM, Prescott T, Rajabi F, Randrianaivo H, Reiter SF, Schuurs-Hoeijmakers J, Shieh PB, Slavotinek A, Smithson S, Stegmann APA, Tomczak K, Tveten K, Wang J, Whitlock JH, Zweier C, McWalter K, Juusola J, Quintero-Rivera F, Fischer U, Yeo NC, Kreienkamp H-J, Lessel D. NM_138615.2(DHX30): c.1385G>A (p.Gly462Glu). Variant #0000763353. LOVD 3.0. https://databases.lovd.nl/shared/variants/0000763353 .
Mannucci I, Dang NDP, Huber H, Murry JB, Abramson J, Althoff T, Banka S, Baynam G, Bearden D, Beleza A, Benke PJ, Berland S, Bierhals T, Bilan F, Bindoff LA, Braathen GJ, L. Busk Ø, Chenbhanich J, Denecke J, Escobar LF, Estes C, Fleischer J, Groepper D, Haaxma CA, Hempel M, Holler-Managan Y, Houge G, Jackson A, Kellogg L, Keren B, Kiraly-Borri C, Kraus C, Kubisch C, Le Guyader G, Ljungblad UW, Brenman LM, Martinez-Agosto JA, Might M, Miller DT, Minks KQ, Moghaddam B, Nava C, Nelson SF, Parant JM, Prescott T, Rajabi F, Randrianaivo H, Reiter SF, Schuurs-Hoeijmakers J, Shieh PB, Slavotinek A, Smithson S, Stegmann APA, Tomczak K, Tveten K, Wang J, Whitlock JH, Zweier C, McWalter K, Juusola J, Quintero-Rivera F, Fischer U, Yeo NC, Kreienkamp H-J, Lessel D. NM_138615.2(DHX30): c.2174G>A (p.Arg725His). Variant #0000763354. LOVD 3.0. https://databases.lovd.nl/shared/variants/0000763354 .
Mannucci I, Dang NDP, Huber H, Murry JB, Abramson J, Althoff T, Banka S, Baynam G, Bearden D, Beleza A, Benke PJ, Berland S, Bierhals T, Bilan F, Bindoff LA, Braathen GJ, L. Busk Ø, Chenbhanich J, Denecke J, Escobar LF, Estes C, Fleischer J, Groepper D, Haaxma CA, Hempel M, Holler-Managan Y, Houge G, Jackson A, Kellogg L, Keren B, Kiraly-Borri C, Kraus C, Kubisch C, Le Guyader G, Ljungblad UW, Brenman LM, Martinez-Agosto JA, Might M, Miller DT, Minks KQ, Moghaddam B, Nava C, Nelson SF, Parant JM, Prescott T, Rajabi F, Randrianaivo H, Reiter SF, Schuurs-Hoeijmakers J, Shieh PB, Slavotinek A, Smithson S, Stegmann APA, Tomczak K, Tveten K, Wang J, Whitlock JH, Zweier C, McWalter K, Juusola J, Quintero-Rivera F, Fischer U, Yeo NC, Kreienkamp H-J, Lessel D. NM_138615.2(DHX30): c.2201C>A (p.Ala734Asp). Variant #0000763355. LOVD 3.0. https://databases.lovd.nl/shared/variants/0000763355 .
Mannucci I, Dang NDP, Huber H, Murry JB, Abramson J, Althoff T, Banka S, Baynam G, Bearden D, Beleza A, Benke PJ, Berland S, Bierhals T, Bilan F, Bindoff LA, Braathen GJ, L. Busk Ø, Chenbhanich J, Denecke J, Escobar LF, Estes C, Fleischer J, Groepper D, Haaxma CA, Hempel M, Holler-Managan Y, Houge G, Jackson A, Kellogg L, Keren B, Kiraly-Borri C, Kraus C, Kubisch C, Le Guyader G, Ljungblad UW, Brenman LM, Martinez-Agosto JA, Might M, Miller DT, Minks KQ, Moghaddam B, Nava C, Nelson SF, Parant JM, Prescott T, Rajabi F, Randrianaivo H, Reiter SF, Schuurs-Hoeijmakers J, Shieh PB, Slavotinek A, Smithson S, Stegmann APA, Tomczak K, Tveten K, Wang J, Whitlock JH, Zweier C, McWalter K, Juusola J, Quintero-Rivera F, Fischer U, Yeo NC, Kreienkamp H-J, Lessel D. NM_138615.2(DHX30): c.2215A>G (p.Thr739Ala). Variant #0000763356. LOVD 3.0. https://databases.lovd.nl/shared/variants/0000763356 .
Mannucci I, Dang NDP, Huber H, Murry JB, Abramson J, Althoff T, Banka S, Baynam G, Bearden D, Beleza A, Benke PJ, Berland S, Bierhals T, Bilan F, Bindoff LA, Braathen GJ, L. Busk Ø, Chenbhanich J, Denecke J, Escobar LF, Estes C, Fleischer J, Groepper D, Haaxma CA, Hempel M, Holler-Managan Y, Houge G, Jackson A, Kellogg L, Keren B, Kiraly-Borri C, Kraus C, Kubisch C, Le Guyader G, Ljungblad UW, Brenman LM, Martinez-Agosto JA, Might M, Miller DT, Minks KQ, Moghaddam B, Nava C, Nelson SF, Parant JM, Prescott T, Rajabi F, Randrianaivo H, Reiter SF, Schuurs-Hoeijmakers J, Shieh PB, Slavotinek A, Smithson S, Stegmann APA, Tomczak K, Tveten K, Wang J, Whitlock JH, Zweier C, McWalter K, Juusola J, Quintero-Rivera F, Fischer U, Yeo NC, Kreienkamp H-J, Lessel D. NM_138615.2(DHX30): c.2345G>A (p.Arg782Gln). Variant #0000763357. LOVD 3.0. https://databases.lovd.nl/shared/variants/0000763357 .
Mannucci I, Dang NDP, Huber H, Murry JB, Abramson J, Althoff T, Banka S, Baynam G, Bearden D, Beleza A, Benke PJ, Berland S, Bierhals T, Bilan F, Bindoff LA, Braathen GJ, L. Busk Ø, Chenbhanich J, Denecke J, Escobar LF, Estes C, Fleischer J, Groepper D, Haaxma CA, Hempel M, Holler-Managan Y, Houge G, Jackson A, Kellogg L, Keren B, Kiraly-Borri C, Kraus C, Kubisch C, Le Guyader G, Ljungblad UW, Brenman LM, Martinez-Agosto JA, Might M, Miller DT, Minks KQ, Moghaddam B, Nava C, Nelson SF, Parant JM, Prescott T, Rajabi F, Randrianaivo H, Reiter SF, Schuurs-Hoeijmakers J, Shieh PB, Slavotinek A, Smithson S, Stegmann APA, Tomczak K, Tveten K, Wang J, Whitlock JH, Zweier C, McWalter K, Juusola J, Quintero-Rivera F, Fischer U, Yeo NC, Kreienkamp H-J, Lessel D. NM_138615.2(DHX30): c.2723G>A (p.Arg908Gln). Variant #0000763358. LOVD 3.0. https://databases.lovd.nl/shared/variants/0000763358 .
Mannucci I, Dang NDP, Huber H, Murry JB, Abramson J, Althoff T, Banka S, Baynam G, Bearden D, Beleza A, Benke PJ, Berland S, Bierhals T, Bilan F, Bindoff LA, Braathen GJ, L. Busk Ø, Chenbhanich J, Denecke J, Escobar LF, Estes C, Fleischer J, Groepper D, Haaxma CA, Hempel M, Holler-Managan Y, Houge G, Jackson A, Kellogg L, Keren B, Kiraly-Borri C, Kraus C, Kubisch C, Le Guyader G, Ljungblad UW, Brenman LM, Martinez-Agosto JA, Might M, Miller DT, Minks KQ, Moghaddam B, Nava C, Nelson SF, Parant JM, Prescott T, Rajabi F, Randrianaivo H, Reiter SF, Schuurs-Hoeijmakers J, Shieh PB, Slavotinek A, Smithson S, Stegmann APA, Tomczak K, Tveten K, Wang J, Whitlock JH, Zweier C, McWalter K, Juusola J, Quintero-Rivera F, Fischer U, Yeo NC, Kreienkamp H-J, Lessel D. NM_138615.2(DHX30): c.347_360del (p. Ala116Valfs*12). Variant #0000763359. LOVD 3.0. https://databases.lovd.nl/shared/variants/0000763359 .
Mannucci I, Dang NDP, Huber H, Murry JB, Abramson J, Althoff T, Banka S, Baynam G, Bearden D, Beleza A, Benke PJ, Berland S, Bierhals T, Bilan F, Bindoff LA, Braathen GJ, L. Busk Ø, Chenbhanich J, Denecke J, Escobar LF, Estes C, Fleischer J, Groepper D, Haaxma CA, Hempel M, Holler-Managan Y, Houge G, Jackson A, Kellogg L, Keren B, Kiraly-Borri C, Kraus C, Kubisch C, Le Guyader G, Ljungblad UW, Brenman LM, Martinez-Agosto JA, Might M, Miller DT, Minks KQ, Moghaddam B, Nava C, Nelson SF, Parant JM, Prescott T, Rajabi F, Randrianaivo H, Reiter SF, Schuurs-Hoeijmakers J, Shieh PB, Slavotinek A, Smithson S, Stegmann APA, Tomczak K, Tveten K, Wang J, Whitlock JH, Zweier C, McWalter K, Juusola J, Quintero-Rivera F, Fischer U, Yeo NC, Kreienkamp H-J, Lessel D. NM_138615.2(DHX30): c.2389C>T (p. Arg797*). Variant #0000763360. LOVD 3.0. https://databases.lovd.nl/shared/variants/0000763360 .
Mannucci I, Dang NDP, Huber H, Murry JB, Abramson J, Althoff T, Banka S, Baynam G, Bearden D, Beleza A, Benke PJ, Berland S, Bierhals T, Bilan F, Bindoff LA, Braathen GJ, L. Busk Ø, Chenbhanich J, Denecke J, Escobar LF, Estes C, Fleischer J, Groepper D, Haaxma CA, Hempel M, Holler-Managan Y, Houge G, Jackson A, Kellogg L, Keren B, Kiraly-Borri C, Kraus C, Kubisch C, Le Guyader G, Ljungblad UW, Brenman LM, Martinez-Agosto JA, Might M, Miller DT, Minks KQ, Moghaddam B, Nava C, Nelson SF, Parant JM, Prescott T, Rajabi F, Randrianaivo H, Reiter SF, Schuurs-Hoeijmakers J, Shieh PB, Slavotinek A, Smithson S, Stegmann APA, Tomczak K, Tveten K, Wang J, Whitlock JH, Zweier C, McWalter K, Juusola J, Quintero-Rivera F, Fischer U, Yeo NC, Kreienkamp H-J, Lessel D. NM_138615.2(DHX30): g.47098509_48109065del. Variant #0000763361. LOVD 3.0. https://databases.lovd.nl/shared/variants/0000763361 .
Mannucci I, Dang NDP, Huber H, Murry JB, Abramson J, Althoff T, Banka S, Baynam G, Bearden D, Beleza A, Benke PJ, Berland S, Bierhals T, Bilan F, Bindoff LA, Braathen GJ, L. Busk Ø, Chenbhanich J, Denecke J, Escobar LF, Estes C, Fleischer J, Groepper D, Haaxma CA, Hempel M, Holler-Managan Y, Houge G, Jackson A, Kellogg L, Keren B, Kiraly-Borri C, Kraus C, Kubisch C, Le Guyader G, Ljungblad UW, Brenman LM, Martinez-Agosto JA, Might M, Miller DT, Minks KQ, Moghaddam B, Nava C, Nelson SF, Parant JM, Prescott T, Rajabi F, Randrianaivo H, Reiter SF, Schuurs-Hoeijmakers J, Shieh PB, Slavotinek A, Smithson S, Stegmann APA, Tomczak K, Tveten K, Wang J, Whitlock JH, Zweier C, McWalter K, Juusola J, Quintero-Rivera F, Fischer U, Yeo NC, Kreienkamp H-J, Lessel D. NM_138615.2(DHX30): g.47882366_47884746del. Variant #0000763362. LOVD 3.0. https://databases.lovd.nl/shared/variants/0000763362 .

Auteurs

Ilaria Mannucci (I)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.

Nghi D P Dang (NDP)

Department of Pharmacology and Toxicology, University of Alabama, Birmingham, USA.

Hannes Huber (H)

Department of Biochemistry, Theodor Boveri Institute, Biocenter of the University of Würzburg, 97070, Würzburg, Germany.

Jaclyn B Murry (JB)

Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
UCLA Clinical Genomics Center, University of California Los Angeles, Los Angeles, CA, USA.

Jeff Abramson (J)

Department of Physiology, University of California Los Angeles, Los Angeles, CA, USA.

Thorsten Althoff (T)

Department of Physiology, University of California Los Angeles, Los Angeles, CA, USA.

Siddharth Banka (S)

Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.
Division of Evolution & Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Gareth Baynam (G)

Faculty of Medicine and Health Sciences, University of Western Australia, Perth, WA, Australia.
Western Australian Register of Developmental Anomalies, King Edward Memorial Hospital, Perth, Australia.
Telethon Kids Institute, Perth, Australia.

David Bearden (D)

Division of Child Neurology, Department of Neurology, University of Rochester School of Medicine, Rochester, NY, USA.

Ana Beleza-Meireles (A)

Clinical Genetics Department, University Hospitals Bristol and Weston, Bristol, UK.

Paul J Benke (PJ)

Joe DiMaggio Children's Hospital, Hollywood, FL, USA.

Siren Berland (S)

Department of Medical Genetics, Haukeland University Hospital, 5021, Bergen, Norway.

Tatjana Bierhals (T)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.

Frederic Bilan (F)

Department of Medical Genetics, Centre Hospitalier Universitaire de Poitiers, Poitiers, France.
Laboratoire de Neurosciences Cliniques et Expérimentales-INSERM U1084, Université de Poitiers, Poitiers, France.

Laurence A Bindoff (LA)

Department of Clinical Medicine (K1), University of Bergen, Bergen, Norway.
Department of Neurology, Haukeland University Hospital, Bergen, Norway.

Geir Julius Braathen (GJ)

Department of Medical Genetics, Telemark Hospital Trust, Skien, Norway.

Øyvind L Busk (ØL)

Department of Medical Genetics, Telemark Hospital Trust, Skien, Norway.

Jirat Chenbhanich (J)

Division of Medical Genetics, Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.

Jonas Denecke (J)

Department of Pediatrics, University Medical Center Eppendorf, 20246, Hamburg, Germany.

Luis F Escobar (LF)

Peyton Manning Children's Hospital, Ascension Health, Indianapolis, IN, USA.

Caroline Estes (C)

Peyton Manning Children's Hospital, Ascension Health, Indianapolis, IN, USA.

Julie Fleischer (J)

Department of Pediatrics, Southern Illinois University School of Medicine, Springfield, IL, 62702, USA.

Daniel Groepper (D)

Department of Pediatrics, Southern Illinois University School of Medicine, Springfield, IL, 62702, USA.

Charlotte A Haaxma (CA)

Department of Pediatric Neurology, Amalia Children's Hospital and Donders Institute for Brain, Cognition and Behavior, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.

Maja Hempel (M)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.

Yolanda Holler-Managan (Y)

Division of Neurology, Department of Pediatrics, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Gunnar Houge (G)

Department of Medical Genetics, Haukeland University Hospital, 5021, Bergen, Norway.

Adam Jackson (A)

Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.
Division of Evolution & Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Laura Kellogg (L)

Kaiser Permanente Sacramento, Sacramento, USA.

Boris Keren (B)

Département de Génétique, Hôpital La Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.

Catherine Kiraly-Borri (C)

Genetic Services of Western Australia, Perth, Western Australia, 6008, Australia.

Cornelia Kraus (C)

Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054, Erlangen, Germany.

Christian Kubisch (C)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.

Gwenael Le Guyader (G)

Department of Medical Genetics, Centre Hospitalier Universitaire de Poitiers, Poitiers, France.
Laboratoire de Neurosciences Cliniques et Expérimentales-INSERM U1084, Université de Poitiers, Poitiers, France.

Ulf W Ljungblad (UW)

Department of Pediatrics, Vestfold Hospital, 3116, Tønsberg, Norway.

Leslie Manace Brenman (LM)

Department of Genetics, Kaiser Permanente Northern California, Oakland, USA.

Julian A Martinez-Agosto (JA)

UCLA Clinical Genomics Center, University of California Los Angeles, Los Angeles, CA, USA.
Semel Institute of Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA, USA.
Department of Pediatrics, Division of Medical Genetics at David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Department of Human Genetics at David Geffen School of Medicine University of California Los Angeles, Los Angeles, CA, USA.

Matthew Might (M)

Department of Medicine, Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, 510 20th St S, Birmingham, AL, 35210, USA.

David T Miller (DT)

Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.

Kelly Q Minks (KQ)

Division of Child Neurology, Department of Neurology, University of Rochester School of Medicine, Rochester, NY, USA.

Billur Moghaddam (B)

Kaiser Permanente Sacramento, Sacramento, USA.

Caroline Nava (C)

Département de Génétique, Hôpital La Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.

Stanley F Nelson (SF)

UCLA Clinical Genomics Center, University of California Los Angeles, Los Angeles, CA, USA.
Department of Human Genetics at David Geffen School of Medicine University of California Los Angeles, Los Angeles, CA, USA.
Center for Duchenne Muscular Dystrophy, University of California Los Angeles, Los Angeles, CA, USA.

John M Parant (JM)

Department of Pharmacology and Toxicology, University of Alabama, Birmingham, USA.

Trine Prescott (T)

Department of Medical Genetics, Telemark Hospital Trust, Skien, Norway.

Farrah Rajabi (F)

Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.

Hanitra Randrianaivo (H)

UF de Génétique Médicale, GHSR, CHU de La Réunion, Saint Pierre, La Réunion, France.

Simone F Reiter (SF)

Department of Medical Genetics, Haukeland University Hospital, 5021, Bergen, Norway.

Janneke Schuurs-Hoeijmakers (J)

Department of Human Genetics, Radboud University Medical Center, 6500 HB, Nijmegen, the Netherlands.

Perry B Shieh (PB)

Department of Neurology at David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.

Anne Slavotinek (A)

Division of Medical Genetics, Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.

Sarah Smithson (S)

Clinical Genetics Department, University Hospitals Bristol and Weston, Bristol, UK.

Alexander P A Stegmann (APA)

Department of Human Genetics, Radboud University Medical Center, 6500 HB, Nijmegen, the Netherlands.
Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.

Kinga Tomczak (K)

Department of Neurology, Boston Children's Hospital, Boston, MA, USA.

Kristian Tveten (K)

Department of Medical Genetics, Telemark Hospital Trust, Skien, Norway.

Jun Wang (J)

Department of Pharmacology and Toxicology, University of Alabama, Birmingham, USA.

Jordan H Whitlock (JH)

Department of Medicine, Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, 510 20th St S, Birmingham, AL, 35210, USA.

Christiane Zweier (C)

Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054, Erlangen, Germany.
Department of Human Genetics, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.

Kirsty McWalter (K)

GeneDx, Gaithersburg, MD, 20877, USA.

Jane Juusola (J)

GeneDx, Gaithersburg, MD, 20877, USA.

Fabiola Quintero-Rivera (F)

Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
UCLA Clinical Genomics Center, University of California Los Angeles, Los Angeles, CA, USA.
Department of Pathology and Laboratory Medicine, School of Medicine, University of California Irvine, Irvine, CA, USA.

Utz Fischer (U)

Department of Biochemistry, Theodor Boveri Institute, Biocenter of the University of Würzburg, 97070, Würzburg, Germany.

Nan Cher Yeo (NC)

Department of Pharmacology and Toxicology, University of Alabama, Birmingham, USA. nyeo@uab.edu.

Hans-Jürgen Kreienkamp (HJ)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany. kreienkamp@uke.de.

Davor Lessel (D)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany. d.lessel@uke.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH